JamesLeonKhatcheressianMD

PubMed

• 18 citations
  Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer
  Linda T. Vahdat, Rachel M. Layman, Denise A. Yardley, William J. Gradishar, Mohamad Adham Salkeni, Anil A. Joy, Agustin A. Garcia, Patrick J. Ward, James Khatcheressia...> ;The Oncologist. 2017 Mar 1
• 212 citations
  Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
  Andrew L. Himelstein, Jared C. Foster, James L. Khatcheressian, John D. Roberts, Drew K. Seisler, Paul J. Novotny, Rui Qin, Ronald S. Go, Stephen Grubbs, Tracey O'Conn...> ;JAMA. 2017 Jan 3
• 379 citations
  Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
  Hope S. Rugo, R. Bryan Rumble, Erin Macrae, Debra L. Barton, Hannah Klein Connolly, Maura N. Dickler, Lesley Fallowfield, Barbara Fowble, James N. Ingle, Mohammad Jaha...> ;Journal of Clinical Oncology. 2016 Sep 27
• 548 citations
  Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
  Thomas J. Smith, Kari Bohlke, Gary H. Lyman, Kenneth R. Carson, Jeffrey Crawford, Scott J. Cross, John M. Goldberg, James Khatcheressian, Natasha B. Leighl, Cheryl L. ...> ;Journal of Clinical Oncology. 2015 Jul 13
• 36 citations
  Pazopanib as second-line treatment after sunitinib or bevacizumab in patients with advanced renal cell carcinoma: a Sarah Cannon Oncology Research Consortium Phase II ...
  John D. Hainsworth, Mark S. Rubin, Edward Arrowsmith, James Khatcheressian, Edward J. Crane, Luis A. Franco> ;Clinical Genitourinary Cancer. 2013 Sep 1
• 393 citations
  Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update
  James Khatcheressian, Patricia Hurley, Elissa T. Bantug, Laura J. Esserman, Eva Grunfeld, Francine E. Halberg, Alexander Hantel, N. Lynn Henry, Hyman B. Muss, Thomas J...> ;Journal of Clinical Oncology. 2013 Mar 1
• 47 citations
  American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women Wi...
  Jennifer J. Griggs, Mark R. Somerfield, Holly Anderson, N. Lynn Henry, Clifford A. Hudis, James Khatcheressian, Ann H. Partridge, Ann Alexis Prestrud, Nancy E. Davidson> ;Journal of Clinical Oncology. 2011 Oct 10
• 84 citations
  A pilot trial of decision aids to give truthful prognostic and treatment information to chemotherapy patients with advanced cancer.
  Thomas J. Smith, Lindsay A. Dow, Enid Virago, James Khatcheressian, Robin K. Matsuyama, Laurel J. Lyckholm> ;The Journal of Supportive Oncology. 2011 Mar 1
• 104 citations
  Giving honest information to patients with advanced cancer maintains hope.
  Thomas J. Smith, Lindsay A. Dow, Enid Virago, James Khatcheressian, Laurel J. Lyckholm, Robin K. Matsuyama> ;Oncology. 2010 May 1
• 8 citations
  'Futile care': what to do when your patient insists on chemotherapy that likely won't help.
  James Khatcheressian, Sara Beth Harrington, Laurel J. Lyckholm, Thomas J. Smith> ;Oncology. 2008 Jul 1
• 11 citations
  Breast cancer follow-up in the adjuvant setting
  James Khatcheressian, Craig Swainey> ;Current Oncology Reports. 2008 Feb 7
• 1 citations
  Response to “Neutropenic Events in Community Practices Reduced by First and Subsequent Cycle Pegfilgrastim Use”
  Thomas J. Smith, James Khatcheressian> ;The Oncologist. 2007 Dec 1
• 5 citations
  Ovarian suppression in the management of premenopausal breast cancer: methods and efficacy in adjuvant and metastatic settings.
  Seaborn Mcdonald Wade, Mary Helen Hackney, James Khatcheressian, Laurie J. Lyckholm> ;Oncology. 2008 Jan 1
• 1 citations
  Symptom-oriented follow-up of early breast cancer - as good as conventional control and sparing resources.
  James Khatcheressian, Thomas J. Smith> ;Onkologie. 2007 Sep 1
• 2 citations
  Review: adding cytotoxic drugs to a chemotherapy regimen increases tumor response rates and toxicity, but not survival in metastatic breast cancer.
  James Khatcheressian, Thomas J. Smith> ;ACP Journal Club. 2007 Jan 1
• 383 citations
  American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting
  James Khatcheressian, Antonio C. Wolff, Thomas J. Smith, Eva Grunfeld, Hyman B. Muss, Victor G. Vogel, Francine E. Halberg, Mark R. Somerfield, Nancy E. Davidson> ;Journal of Clinical Oncology. 2006 Nov 1
• 1144 citations
  2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline
  Thomas J. Smith, James Khatcheressian, Gary H. Lyman, Howard Ozer, James O. Armitage, Lodovico Balducci, Charles L. Bennett, Scott B. Cantor, Jeffrey Crawford, Scott J...> ;Journal of Clinical Oncology. 2006 Jul 1
• 38 citations
  Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care
  James Khatcheressian, Thomas J. Smith> ;Journal of Clinical Oncology. 2006 Feb 20
• 8 citations
  Review: chemotherapy and hormonal therapy reduce recurrence and mortality at 15 years in early breast cancer.
  Thomas J. Smith, James Khatcheressian> ;ACP Journal Club. 2005 Dec 1
• 17 citations
  Improving palliative and supportive care in cancer patients.
  James Khatcheressian, J. Brian Cassel, Patrick J. Coyne, Alice Hagenmueller, Thomas J. Smith> ;Oncology. 2005 Sep 1
• Erythropoietin use in medically underserved patients (pts).
  Khatcheressian J, Smith T, Lyckholm L, Hansen LA, Shickle L> ;J. Clin. Oncol.. 2004-07-15
• Join now to see all

Abstracts/Posters

• Rapid and Durable Responses with the SYK/JAK Inhibitor Cerdulatinib in a Phase 2 Study in Relapsed/Refractory Follicular Lymphoma„Alone or in Combination with Rituximab
  James L. Khatcheressian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019